A detailed history of Marshall & Sullivan Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Marshall & Sullivan Inc holds 2,450 shares of MRK stock, worth $288,732. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,450
Previous 2,450 -0.0%
Holding current value
$288,732
Previous $323,000 6.19%
% of portfolio
0.16%
Previous 0.17%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022

BUY
$73.51 - $82.4 $180,099 - $201,880
2,450 New
2,450 $201,000
Q1 2021

May 04, 2021

SELL
$68.86 - $81.11 $13,772 - $16,222
-200 Closed
0 $0
Q4 2020

Jan 29, 2021

SELL
$71.77 - $79.65 $161,482 - $179,212
-2,250 Reduced 91.84%
200 $2.45 Million
Q2 2020

Jul 14, 2020

BUY
$70.42 - $80.13 $172,529 - $196,318
2,450 New
2,450 $189,000
Q1 2020

May 06, 2020

SELL
$63.36 - $87.82 $155,232 - $215,158
-2,450 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$69.58 - $79.36 $170,471 - $194,432
2,450 New
2,450 $204,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $299B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Marshall & Sullivan Inc Portfolio

Follow Marshall & Sullivan Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall & Sullivan Inc , based on Form 13F filings with the SEC.

News

Stay updated on Marshall & Sullivan Inc with notifications on news.